|
Author | Incidence of IOP elevation (%) | Definition of IOP elevation | Type of surgical intervention | Gas | Risk factors for IOP elevation |
|
Abrams et al. [28] | 45 | ≥30 mmHg in the early postoperative period | PPV with SF6 to reform soft eyes | SF6 20–100% | Eyes with postoperative fibrinous anterior chamber exudates, 100% gas concentration |
Chang et al. [26] | 58.9 | >22 mmHg within the first postoperative week | PPV for complicated retinal detachment | C2F6–C3F8 in various concentrations | N/A |
The Silicone Study Group [29] | 8.7 | ≥30 mmHg at any postoperative visit | PPV in eyes with proliferative vitreoretinopathy and prior vitrectomy | C3F8 14% | N/A |
The Silicone Study Group [30] | 6.1 | ≥30 mmHg at any postoperative visit | PPV in eyes with proliferative vitreoretinopathy and prior vitrectomy | SF6 20% | N/A |
Wong et al. [31] | 21.7 | >30 mmHg on postoperative Day-1 | PPV with or without phacoemulsification cataract surgery | C3F8 16% | N/A |
Wong et al. [31] | 20.4 | >30 mmHg on postoperative Day-1 | PPV with or without phacoemulsification cataract surgery | SF6 30% | N/A |
Chen and Thompson [32] | 43 | >25 mmHg in early postoperative period | PPV with or without scleral buckling | SF6 10–30% or C3F8 5%–35% | Increasing patient age; expansile gas concentrations; use of C3F8; circumferential scleral buckles |
Chen [33] | 52 | >30 mmHg within 1 week after surgery | PPV for macular hole surgery | C3F8 14% | N/A |
Mittra et al. [34] | 52.4 (>25 mmHg) 28.6 (>30 mmHg) | Elevation 4–6 hours postoperatively | PPV | SF6 18%–20% or C3F8 12%–16% | N/A |
Wong et al. [5] | 0.5–1.3 | N/A | Vitreoretinal surgery | N/A | N/A |
|